Lupin gets US FDA approval for Tiotropium dry powder inhaler
This product will be manufactured at Lupin’s Pithampur facility in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin gets US FDA approval for Diazepam Rectal Gel
It is a generic equivalent of Diastat AcuDialTM Rectal Delivery System, 10 mg and 20 mg, of Bausch Health US
Lupin Diagnostics launches Regional Reference Laboratory in Bengaluru
After establishing presence in Hyderabad, this launch expands footprint in South India
Lupin gets tentative US FDA approval for Valbenazine capsules
Valbenazine is indicated for the treatment of tardive dyskinesia (uncontrollable movement of face, tongue, or other body parts)
Lupin receives EIR from US FDA for its injectable facility in Nagpur
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
Lupin launches neuro-rehabilitation center in Mumbai
The neuro-rehabilitation center includes an end-effector based robotic solution
LPC 150 Conclave to be held at NIPER Hyderabad on March 12, 2023
The theme of the event is Pharma 4.0: Digital transformation across pharmaceuticals
Lupin gets USFDA approval for Glycopyrrolate Injection, USP
The product marks the first approval from Lupin’s new injectable facility in Nagpur, India
USFDA gives tentative approval to Lupin’s Dolutegravir and Rilpivirine tablets
The tablets are used to treat HIV infection
USFDA approves Prasugrel tablets by Lupin
The product will be manufactured at Lupin’s facility in Goa